Comorbid depressive symptoms in the developmental course of adolescent-onset psychosis

Early Intervention in Psychiatry

Volumn 1, Issue 2, 2007, Pages 183-190

  Myles Worsley, Marina ^a,b   Weaver, Starla ^b   Blailes, Francisca ^c  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c Palau Ministry of Health   (Palau)

Author keywords

Depression; High risk adolescents; Isolated population; Psychosis; Schizophrenia

Indexed keywords

EID: 77953011862     PISSN: 17517885     EISSN: 17517893     Source Type: Journal    
DOI: 10.1111/j.1751-7893.2007.00022.x     Document Type: Article

References (31)

1. Siris SG, Bench C. Depression and schizophrenia. In: Hirsch SR, Weinberger DR, eds. Schizophrenia, 2nd edn. Oxford: Blackwell Publishing, 2003; 142-67.
2. Hafner H, Maurer K, Trendler G, an der Heiden W, Schmidt M, Konnecke R. Schizophrenia and depression: challenging the paradigm of two separate diseases-a controlled study of schizophrenia, depression and healthy controls. Schizophr Res 2005; 77: 11-24.
3. Kitamura T, Okazaki Y, Fujinawa A, Yoshino M, Kasahara Y. (1995). Symptoms of psychoses: a factor-analytic study. Br J Psychiatry 1995; 166: 236-40.
4. Lenzenweger MF, Dworkin RH. The dimensions of schizophrenia phenomenology: not one or two, at least three, perhaps four. Br J Psychiatry 1996; 68: 432-40.
5. McGorry PD, Bell RC, Dudgeon PL, Jackson HJ. The dimensional structure of first episode psychosis: an exploratory factor analysis. Psychol Med 1998; 28: 935-47.
6. Van Os J, Gilvarry C, Bale R et al. A comparison of the utility of dimensional and categorical representations of psychosis. Psychol Med 1999; 29: 595-606.
7. Blanchard JJ, Cohen AS. The structure of negative symptoms within schizophrenia: implications for assessment. Schizophr Bull 2006; 32: 238-45.
8. Hafner H, Loffler W, Maurer K, Hambrecht M, an der Heiden W. Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiatr Scand 1999; 100: 105-18.
9. Meyer SE, Bearden CE, Lux SR et al. The psychosis prodrome in adolescent patients viewed through the lens of DSM-IV. J Child Adol Psychopharmacol 2005; 15: 434-51.
10. Yung AR, McGorry PD. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull 1996; 22: 353-70.
11. Hafner H, Maurer K, Loffler W et al. The ABC Schizophrenia Study: a preliminary overview of the results. Soc Psychiatry Psychiatr Epidemiol 1998; 33: 380-6.
12. Hafner H. Onset and early course as determinants of the further course of schizophrenia. Acta Psychiatr Scand 2000; 407: 44-8.
13. Hafner H, Riecher-Rossler A, Hambrecht M et al. IRAOS: an instrument for the assessment of onset and early course of schizophrenia. Schizophr Res 1992; 6: 209-23.
14. An der Heiden W, Hafner H. The epidemiology of onset and course of schizophrenia. Eur Arch Psychiatry Clin Neurosci 2000; 250: 292-303.
15. Singh SP, Cooper JE, Fisher HL et al. Determining the chronology and components of psychosis onset: the Nottingham Onset Schedule (NOS). Schizophr Res 2005; 80: 117-30.
16. Klosterkotter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 2001; 58: 158-64.
17. Gross G, Huber G, Klosterkotter J, Linz M. BSABS: Bonn Scale for the Assessment of Basic Symptoms. Berlin, Heidelberg, NY: Springer, 1997.
18. Krabbendam L, Myin-Germeys I, Hanssen M et al. Development of depressed mood predicts onset of psychotic disorder in individuals who report hallucinatory experiences. Br J Clin Psychol 2005; 44: 113-25.
19. Yung AR, Phillips LJ, Yuen HP, McGorry PD. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr Res 2004; 67: 131-42.
20. Cornblatt BA, Lencz T, Smith CW et al. The schizophrenia prodrome revisited: a neurodevelopmental perspective. Schizophr Bull 2003; 29: 633-51.
21. LenczT, Smith CW, Auther A, Correll CU, Cornblatt B. Nonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophrenia. Schizophr Res 2004; 68: 37-48.
22. Myles-Worsley M, Coon H, Tiobech J et al. Genetic epidemiological study of schizophrenia in Palau, Micronesia: prevalence and familiality. Am J Med Genet: Neuropsychiatr Genet 1999; 88: 4-10.
23. Myles-Worsley M, Blailes F, Ord LM, Weaver S, Dever G, Faraone S. The Palau Early Psychosis Study: distribution of cases by level of genetic risk. Am J Med Genet: Neuropsychiatr Genet 2007; 144: 5-9.
24. Ord LM, Myles-Worsley M, Blailes F, Ngiralmau H. Screening for prodromal adolescents in an isolated high-risk population. Schizophr Res 2004; 71: 507-8.
25. Kaufman J, Birmaher B, Brent D et al. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997; 36: 980-8.
26. Yung AR, Yuen HP, McGorry PD et al. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust N Z J Psychiatry 2005; 39: 964-71.
27. McGorry PD, Yung AR, Phillips LJ. The 'close-in' or ultra highrisk model: a safe and effective strategy for research and clinical intervention in prepsychotic mental disorder. Schizophr Bull 2003; 29: 771-90.
28. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994.
29. Owens DG, Miller P, Lawrie SM, Johnstone EC. Pathogenesis of schizophrenia: a psychopathological perspective. Br J Psychiatry 2005; 186: 386-93.
30. Miller TJ, McGlashan TH, Rosen J et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull 2003; 29: 703-15.
31. Olsen KA, Rosenbaum B. Prospective investigations of the prodromal state of schizophrenia: assessment instruments. Acta Psychiatr Scand 2006; 113: 273-82.